Company intelligence / Profile preview

Profarma

Ownership: Private
Employees: ~90
Development stage: Commercial

Overview

Profarma is an EU GMP-certified biopharmaceutical company based in Vilnius, Lithuania. It specializes in high-quality analytical services supporting the entire drug product lifecycle—from development and clinical support to EU batch release testing and Qualified Person (QP) certification. The company serves manufacturers and distributors with quality control for biological molecules, chemical compounds, advanced therapies, vaccines, and drug-device combination products. With over 17 years in business, it routinely tests more than 100 different products from over 20 countries.

Modalities: Small moleculesPeptidesBiologics (including biosimilars)Vaccines
Industry: Contract Research Organization

Partnerships

collaborations with pharmaceutical manufacturers for routine product testing

Beyond the preview

Go deeper on Profarma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Profarma.

Explore the full profile